Cited by 1,095Neurofibromatosis and Schwannoma CasesProtein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

The neurofibromatosis type 1 gene encodes a protein related to GAP

Xu, Gangfeng, O'Connell, Peter, Viskochil, David, Cawthon, Richard, Robertson, Margaret, Culver, Melanie, Dunn, Diane, Stevens, Jeff, Gesteland, Ray, White, Ray, Weiss, Robert·1990·Cell

DOI 10.1016/0092-8674(90)90024-9

Open this paper in CoChat — free account

Abstract

cDNA walking and sequencing have extended the open reading frame for the neurofibromatosis type 1 gene (NF1). The new sequence now predicts 2485 amino acids of the NF1 peptide. A 360 residue region of the new peptide shows significant similarity to the known catalytic domains of both human and bovine GAP (GTPase activating protein). A much broader region, centered around this same 360 amino acid sequence, is strikingly similar to the yeast IRA1 product, which has a similar amino acid sequence and functional homology to mammalian GAP. This evidence suggests that NF1 encodes a cytoplasmic GAP-like protein that may be involved in the control of cell growth by interacting with proteins such as the RAS gene product. Mapping of the cDNA clones has confirmed that NF1 spans a t(1;17) translocation mutation and that three active genes lie within an intron of NF1, but in opposite orientation.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(90)90024-9

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,927
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90381-6 · Cited by 4,952
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ
Benton, W. D., & Davis, R. W. (1977) · Science · doi:10.1126/science.322279 · Cited by 4,520
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,259
[5] Rapid and sensitive sequence comparison with FASTP and FASTA
Pearson, W. R. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)83007-v · Cited by 1,934
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J. M., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,478

Show all 42 references

Research works printed but not linked: 1

Stumpf, 1987, Neurofibromatosis, Arch. Neurol., 45, 575

Sorted by citations

Oncogenes and signal transduction
Cantley, L. C., Auger, K. R., Carpenter, C. F., Duckworth, B. C., Graziani, A., Kapeller, R., & Soltoff, S. P. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,697
The GTPase superfamily: a conserved switch for diverse cell functions
Bourne, H. R., Sanders, D. A. R., & McCormick, F. P. (1990) · Nature · doi:10.1038/348125a0 · Cited by 2,336
Mammalian Ras interacts directly with the serine/threonine kinase raf
Vojtek, A. B., Hollenberg, S. M., & Cooper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90307-c · Cited by 1,934
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
SH2 and SH3 Domains: Elements that Control Interactions of Cytoplasmic Signaling Proteins
Koch, C. A., Anderson, D. H., Moran, M. F., Ellis, C. A., & Pawson, T. J. (1991) · Science · doi:10.1126/science.1708916 · Cited by 1,868
Tumor Suppressor Genes
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,765
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,629
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997) · Science · doi:10.1126/science.277.5324.333 · Cited by 1,543
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
“Soon thereafter, the second RasGAP, neurofibromin-1 ( NF1 ), was identified and found to be disrupted in patients with neurofibromatosi”
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
Trofatter, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,390
RAS-targeted therapies: is the undruggable drugged?
Moore, A. R., Rosenberg, S. C., McCormick, F., & Malek, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0068-6 · Cited by 1,103
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Ferner, R. E., Huson, S., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M. J., Steiger, C., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045906 · Cited by 1,049
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
Martin, G. A., Viskoohil, D., Bollag, G. E., McCabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O'Connell, P., Cawthon, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90150-d · Cited by 983
Self-citation
The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions
Woods, D. F., & Bryant, P. J. (1991) · Cell · doi:10.1016/0092-8674(81)90009-x · Cited by 898
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M., & Collins, F. (1990) · Cell · doi:10.1016/0092-8674(90)90151-4 · Cited by 847
“Under our assay conditions, NF1 lysates have less activity than lysates from cells expressing GAP Discussion The NFl locus encodes a protein that is structurally related to the IRA proteins of yeast and to the GAP protein of mammalian cells (Xu et al., 1990; Buchberg et al., 1990).”
BackgroundMethodResultInfluential
Human RAS Superfamily Proteins and Related GTPases
Colicelli, J. (2004) · Science s STKE · doi:10.1126/stke.2502004re13 · Cited by 875
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1
Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., & Weinberg, R. A. (1994) · Nature Genetics · doi:10.1038/ng0794-353 · Cited by 780
Antioncogenes and human cancer.
Knudson, A. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10914 · Cited by 772
Tumor suppressor genes
Marshall, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90641-b · Cited by 752
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Holmfeldt, L., Wei, L., Díaz-Flores, E., Walsh, M. F., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M. L., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 738
The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae
Xu, G., Lin, B. K., Tanaka, K., Dunn, D. M., Wood, D. R., Gesteland, R. F., White, R. L., Weiss, R. B., & Tamanoi, F. (1990) · Cell · doi:10.1016/0092-8674(90)90149-9 · Cited by 681
Self-citation
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., & Downward, J. (1992) · Nature · doi:10.1038/356713a0 · Cited by 669
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Ostrem, J. M. L., & Shokat, K. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.139 · Cited by 641
Heart Valve Development
Armstrong, E. J., & Bischoff, J. E. (2004) · Circulation Research · doi:10.1161/01.res.0000141146.95728.da · Cited by 669
Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.
Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., & Copeland, N. G. (1994) · Genes & Development · doi:10.1101/gad.8.9.1019 · Cited by 641
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brainPreprint
Zhu, Y., Romero‐Ortega, M. I., Ghosh, P., Ye, Z., Charnay, P., Rushing, E. J., Marth, J. D., & Parada, L. F. (2001) · Genes & Development · doi:10.1101/gad.862101 · Cited by 606
“Loss of heterozygosity (LOH) at the NF1 locus has been identified in pheochromocytomas (Xu et al. 1992), neurofibrosarcomas (Legius et al. 1993), and myeloid leukemias (Side et al. 1997).”
Background
NF1 Tumor Suppressor Gene Function
Cichowski, K. M., & Jacks, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00245-8 · Cited by 603
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
Ferner, R. E., & Gutmann, D. H. (2002) · PubMed · Cited by 603
Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
DeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C., & Lowy, D. R. (1992) · Cell · doi:10.1016/0092-8674(92)90407-4 · Cited by 580
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations
Listernick, R., Ferner, R. E., Liu, G. T., & Gutmann, D. H. (2007) · Annals of Neurology · doi:10.1002/ana.21107 · Cited by 574
Highly parallel identification of essential genes in cancer cells
Luo, B., Cheung, H. W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., Hinkle, G., Boehm, J. S., Beroukhim, R., Weir, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810485105 · Cited by 541
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
Ferner, R. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70075-3 · Cited by 511
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Ratner, N., & Miller, S. J. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3911 · Cited by 503
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
Jensen, R. T., Berna, M. J., Bingham, D. B., & Norton, J. A. (2008) · Cancer · doi:10.1002/cncr.23648 · Cited by 487
Neurofibromatosis type 1
Boyd, K. P., Korf, B. R., & Theos, A. J. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.12.051 · Cited by 486
Cortical Actin Organization: Lessons from ERM (Ezrin/Radixin/Moesin) Proteins
Tsukita, S., & Yonemura, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34507 · Cited by 470
Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the nf1 optic pathway glioma task force
Listernick, R., Louis, D. N., Packer, R. J., & Gutmann, D. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410204 · Cited by 469
Amino acids and mTORC1: from lysosomes to disease
Efeyan, A., Zoncu, R., & Sabatini, D. M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.05.007 · Cited by 436
Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning
Cui, Y., Costa, R. M., Murphy, G. G., Elgersma, Y., Zhu, Y., Gutmann, D. H., Parada, L. F., Módy, I., & Silva, A. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.060 · Cited by 445
“Neurofibromin, a Ras GPTase-activating protein (RasGAP) encoded by the neurofibromatosis type I (NF1) gene (Martin et al., 1990; Xu et al., 1990), is thought to modulate Ras/ERK signaling, LTP, and learning in mice (Costa et al.”
Loss of The Normal NF1 Allele from the Bone Marrow of Children with Type 1 Neurofibromatosis and Malignant Myeloid Disorders
Shannon, K., O'Connell, P., Martin, G. A., Paderanga, D., Olson, K., Dinndorf, P. A., & McCormick, F. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300903 · Cited by 440
Self-citation
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Uusitalo, E., Rantanen, M. E., Kallionpää, R. A., Pöyhönen, M., Leppävirta, J., Ylä‐Outinen, H., Riccardi, V. M., Pukkala, ., Pitkäniemi, J. M., Peltonen, S. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3576 · Cited by 423
Somatic mutations in the neurofibromatosis 1 gene in human tumors
Li, Y., Bollag, G. E., Clark, R., Stevens, J., Conroy, L., Fults, D., Ward, K., Friedman, E., Samowitz, W. S., Robertson, M. A., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90408-5 · Cited by 394
Self-citation
cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene product
Marchuk, D. A., Saulino, A. M., Tavakkol, R., Swaroop, M., Wallace, M. R., Andersen, L. B., Mitchell, A. L., Gutmann, D. H., Boguski, M. S., & Collins, F. S. (1991) · Genomics · doi:10.1016/0888-7543(91)90017-9 · Cited by 390
Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis
Woodruff, J. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1 · Cited by 228
Requirement for a GTPase-Activating Protein in Vesicle Budding from the Endoplasmic Reticulum
Yoshihisa, T., Barlowe, C. K., & Schekman, R. W. (1993) · Science · doi:10.1126/science.8451644 · Cited by 384
Deletion of IRF-1 , Mapping to Chromosome 5q31.1, in Human Leukemia and Preleukemic Myelodysplasia
Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F., et al. (1993) · Science · doi:10.1126/science.8438156 · Cited by 380
Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras
Ahmadian, M. R., Stege, P., Scheffzek, K., & Wittinghofer, A. (1997) · Nature Structural Biology · doi:10.1038/nsb0997-686 · Cited by 370
Mouse Tumor Model for Neurofibromatosis Type 1
Vogel, K. S., Klesse, L. J., Velasco-Miguel, S., Meyers, K. A., Rushing, E. J., & Parada, L. F. (1999) · Science · doi:10.1126/science.286.5447.2176 · Cited by 373
Molecular genetics of neurofibromatosis type 1 (NF1).
Shen, M. H., Harper, P. S., & Upadhyaya, M. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.1.2 · Cited by 371
GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila
Bernards, A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00082-3 · Cited by 374
A Comprehensive Genetic Linkage Map of the Human Genome
NIH/CEPH Collaborative Mapping Group (1992) · Science · doi:10.1126/science.1439770 · Cited by 358
A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center
Kim, D. H., Murovic, J. A., Tiel, R. L., Moes, G., & Kline, D. G. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.2.0246 · Cited by 342
GENE DISCOVERY INDROSOPHILA: New Insights for Learning and Memory
Dubnau, J., & Tully, T. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.407 · Cited by 336
“In mammals,NF1 is believed to function as a GTPase-activating protein for Ras (Ras-GAP) and therefore as a negative regulator of Ras (Ballester et al 1990; Buckberg et al 1990; Martin et al 1990; Xu et al 1990a,b).”
Background
Malignancy in Neurofibromatosis Type 1
Korf, B. R. (2000) · The Oncologist · doi:10.1634/theoncologist.5-6-477 · Cited by 328
Sst2, a Negative Regulator of Pheromone Signaling in the Yeast Saccharomyces cerevisiae: Expression, Localization, and Genetic Interaction and Physical Association with Gpa1 (the G-Protein α Subunit)
Dohlman, H. G., Song, J., Ma, D., Courchesne, W. E., & Thorner, J. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5194 · Cited by 323
“Both GAP and NF-1 stimulate in vitro GTP hydrolysis by the low-molecular-weight G-protein p21ras (71, 118).”
BackgroundInfluential
DNA methylation and cancer
Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 323
The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes
Daston, M. M., Scrable, H. J., Nordlund, M. L., Sturbaum, A. K., Nissen, L. M., & Ratner, N. (1992) · Neuron · doi:10.1016/0896-6273(92)90270-n · Cited by 314
Minor Lesion Mutational Spectrum of the Entire NF1 Gene Does Not Explain Its High Mutability but Points to a Functional Domain Upstream of the GAP-Related Domain
Fahsold, R., Hoffmeyer, S., Mischung, C., Gille, C., Ehlers, C., Kücükceylan, N., Abdel-Nour, M., Gewies, A., Hartmut Peters, A., Kaufmann, D., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302809 · Cited by 313
“A central region of about 360 amino acids shows significant homology to the mammalian GTPase-activating protein (GAP) (Xu et al. 1990).”
BackgroundInfluential
Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1–Associated Human and Mouse Brain Tumors
Dasgupta, B., Yi, Y., Chen, D. Y., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4058 · Cited by 308
“Previous studies have shown that the NF1 gene encodes a protein termed neurofibromin, which contains a small domain with sequence similarity to a family of proteins that function to inhibit RAS activation (4).”
Background
NF1-Associated Gastrointestinal Stromal Tumors Have Unique Clinical, Phenotypic, and Genotypic Characteristics
Andersson‐Assarsson, J. C., Sihto, H. J., Meis‐Kindblom, J. M., Joensuu, H., Nupponen, N. N., & Kindblom, L. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000159775.77912.15 · Cited by 302
“2, encodes neurofibromin, which is a member of the GTPase activating protein (GAP) family of the RAS regulatory proteins.(46) Neurofibromin stimulates GTPase activity and negatively regulates RAS by catalyzing the conversion of the active GTP-bound RAS to its inactive GDP-bound form.”
Background
Regulators And Effectors Of Ras Proteins
Bollag, G. E., & McCormick, F. P. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.003125 · Cited by 302
Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?
Reuter, C. W., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655 · Cited by 300
Homozygous Inactivation of theNF1Gene in Bone Marrow Cells from Children with Neurofibromatosis Type 1 and Malignant Myeloid Disorders
Side, L. E., Taylor, B. R., Cayouette, M. C., Conner, E. R., Thompson, P., Luce, M. C., & Shannon, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362404 · Cited by 294
How many genes in the human genome?
Fields, C., Adams, M. D., White, O. R., & Venter, J. C. (1994) · Nature Genetics · doi:10.1038/ng0794-345 · Cited by 291
Mutational and Kinetic Analyses of the GTPase-Activating Protein (GAP)-p21 Interaction: The C-Terminal Domain of GAP Is Not Sufficient for Full Activity
Gideon, P., John, J., Frech, M., Lautwein, A., Clark, R., Scheffler, J. E., & Wittinghofer, A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2050 · Cited by 287
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study
Ferner, R. E., Golding, J. F., Smith, M. A., Calonje, E. J., Jan, W., Sanjayanathan, V., & O'Doherty, M. J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm450 · Cited by 283
“Neurofibromin, the NF1 gene product, acts as a tumour suppressor by promoting the inactivation of the proto-oncogene p21RAS and by controlling the mammalian target of rapamycin [2, 3].”
RASA1: variable phenotype with capillary and arteriovenous malformations
Boon, L. M., Mulliken, J. B., & Vikkula, M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.03.004 · Cited by 282
“RASA1 belongs to a family of four homologous proteins: RASA1, RASA2 (GAPM1), NF1 (neurofibromin) and RASAL (GAP1-like protein) [25–28].”
Background
Insulin stimulation of gene expression mediated by p21ras activation.
Burgering, B. M. T., Medema, R. H., Maassen, J. A., van de Wetering, M., van der Eb, A. J., McCormick, F. P., & Bos, J. L. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08050.x · Cited by 280
Identification of the neurofibromatosis type 1 gene product.
Gutmann, D. H., Wood, D., & Collins, F. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9658 · Cited by 279
A putative Ras GTPase activating protein acts as a negative regulator of signaling by the Sevenless receptor tyrosine kinase
Gaul, U., Mardon, G., & Rubin, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90073-l · Cited by 278
Linkage of Familial Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis) to Chromosome 17q25
Yamauchi, T., Tada, M., Houkin, K., Tanaka, T., Nakamura, Y., Kuroda, S., Abe, H., Inoue, T. K., 池崎, 清., Matsushima, T., et al. (2000) · Stroke · doi:10.1161/01.str.31.4.930 · Cited by 276
Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein.
Moran, M. F., Polakis, P. G., McCormick, F. P., Pawson, T. J., & Ellis, C. A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1804 · Cited by 266
Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms
Dunlop, E. A., & Tee, A. R. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.012 · Cited by 263
Rescue of a Drosophila NF1 Mutant Phenotype by Protein Kinase A
The, I., Hannigan, G. E., Cowley, G. S., Reginald, S., Zhong, Y., Gusella, J. F., Hariharan, I. K., & Bernards, A. (1997) · Science · doi:10.1126/science.276.5313.791 · Cited by 257
Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations
Serra, E. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3055 · Cited by 254
Prohibitin, an Evolutionarily Conserved Intracellular Protein That Blocks DNA Synthesis in Normal Fibroblasts and HeLa Cells
Nuell, M. J., Stewart, D. A., Walker, L., Friedman, V., Wood, C. M., Owens, G. A., Smith, J. R., Schneider, E. L., Orco, R. D., Lumpkin, C. K., et al. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1372 · Cited by 246
Neurofibromatosis and early onset of cancers in hMLH1-deficient children.
Wang, Q., Lasset, C., Desseigne, F., Frappaz, D., Bergeron, C., Navarro, C., Ruano, E., & Puisieux, A. (1999) · PubMed · Cited by 246
Molecular pathways in the formation of gliomas
von Deimling, A., Louis, D. N., & Wiestler, O. D. (1995) · Glia · doi:10.1002/glia.440150312 · Cited by 245
Confirmation of a Double-Hit Model for the NF1Gene in Benign Neurofibromas
Serra, E., Puig, S., Otero, D., Gaona, A., Kruyer, H., Ars, E., Estivill, X., & Lázaro, C. (1997) · The American Journal of Human Genetics · doi:10.1086/515504 · Cited by 241
The molecular biology of carcinogenesis
Pitot, H. C. (1993) · Cancer · doi:10.1002/1097-0142(19930801)72:3+ · Cited by 242
rho family GTPase activating proteins p190, bcr and rhoGAP show distinct specificities in vitro and in vivo
Ridley, A. J., Self, A. J., Kasmi, F., Paterson, H. F., Hall, A., Marshall, C. J., & Ellis, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06210.x · Cited by 238
Genomic organization of the neurofibromatosis 1 gene (NF1)
Li, Y., O'Connell, P., Breidenbach, H. H., Cawthon, R., Stevens, J., Xu, G., Neil, S. M., Robertson, M. A., White, R. L., & Viskochil, D. H. (1995) · Genomics · doi:10.1016/0888-7543(95)80104-t · Cited by 240
Self-citation
Identification of a human rasGAP-related protein containing calmodulin-binding motifs.
Weissbach, L., Settleman, J. E., Kalady, M. F., Snijders, A. J., Murthy, A. E., Yan, Y. X., & Bernards, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32023-9 · Cited by 235
Plasticity and injury in the developing brain
Johnston, M. V., Ishida, A., Nakajima, W., Matsushita, H., Nishimura, A., & Tsuji, M. (2008) · Brain and Development · doi:10.1016/j.braindev.2008.03.014 · Cited by 243
“For example, neurofibromatosis type 1 (NF-1) is caused by a mutation in the tumor suppressor gene for the protein neurofibromin, which is a GTPase activating protein (GAP) [25].”
Neurofibromatosis type 1 (NF1)
Ferner, R. E., & Gutmann, D. H. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00053-9 · Cited by 230
“conversion of the Ras proto-oncogene from its active, GTP-bound to its inactive GDP-bound form (Xu et al., 1990).”
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Zhu, C., Guan, X., Zhang, X., Luan, X., Song, Z., Cheng, X., Zhang, W., & Qin, J.-J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01629-2 · Cited by 231
Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain.
Campagnoni, A. T., Pribyl, T. M., Campagnoni, C. W., Kampf, K., Amur-Umarjee, S. G., Landry, C. F., Handley, V., Newman, S. L., Garbay, B., & KITAMURA, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53485-2 · Cited by 224
Cooperating oncogenes converge to regulate cyclin/cdk complexes.Preprint
Lloyd, A. C., Obermüller, F., Staddon, S., Barth, C. F., McMahon, M., & Land, H. (1997) · Genes & Development · doi:10.1101/gad.11.5.663 · Cited by 224
The NF1 gene in tumor syndromes and melanoma
Kiuru, M. H., & BUSAM, K. J. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2016.142 · Cited by 229
GTPase activating proteins: critical regulators of intracellular signaling
Donovan, S., Shannon, K., & Bollag, G. E. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00041-5 · Cited by 215
Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue, J. E., Cohen, B. D., & Lowy, D. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9914 · Cited by 215
Neurocristopathies: New insights 150 years after the neural crest discovery
Vega‐López, G. A., Cerrizuela, S., Tríbulo, C., & Aybar, M. J. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.05.013 · Cited by 219
A Comprehensive Genetic Linkage Map of the Human Genome
Donis-Keller, H. (1992) · Science · Cited by 210
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.
Kayes, L. M., Burke, W., Riccardi, V. M., Bennett, R. L., Ehrlich, P., Rubenstein, A. E., & Stephens, K. G. (1994) · PubMed Central · Cited by 209
Requirement of Drosophila NF1 for Activation of Adenylyl Cyclase by PACAP38-Like Neuropeptides
Guo, H.-F., The, I., Hannan, F., Bernards, A., & Zhong, Y. (1997) · Science · doi:10.1126/science.276.5313.795 · Cited by 209
Mutations of the NF1 Gene in Children With Juvenile Myelomonocytic Leukemia Without Clinical Evidence of Neurofibromatosis, Type 1
Side, L. E., Emanuel, P. D., Taylor, B. R., Franklin, J. L., Thompson, P., Castleberry, R. P., & Shannon, K. (1998) · Blood · doi:10.1182/blood.v92.1.267.413a31_267_272 · Cited by 205
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs
Le, L. Q., & Parada, L. F. (2007) · Oncogene · doi:10.1038/sj.onc.1210261 · Cited by 205
“2 and was identified by positional cloning in 1990 (Ballester et al., 1990; Xu et al., 1990).”
The N‐terminal region of GAP regulates cytoskeletal structure and cell adhesion.
McGlade, J. C., Brunkhorst, B. A., Anderson, D. M., Mbamalu, G., Settleman, J. E., Dedhar, S., Rozakis-Adcock, M., Chen, L. B., & Pawson, T. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05976.x · Cited by 202

Authors: Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., & Weiss, R.
Affiliations: Howard Hughes Medical Institute (US)
University of Utah (US)
ORCID: O'Connell, Peter
Viskochil, David
Cawthon, Richard
Culver, Melanie
Stevens, Jeff
Weiss, Robert
Venue: Cell
Publisher: Elsevier BV
Published: 1990-08
Volume: 62
Issue: 3
Pages: 599-608
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/0092-8674(90)90024-9
OpenAlex: W2159096148
Cited by: 1,095
References: 42
Citations by year: 2026: 7 · 2025: 13 · 2024: 19 · 2023: 19 · 2022: 22 · 2021: 22 · 2020: 22 · 2019: 18 · 2018: 22 · 2017: 17 · 2016: 19 · 2015: 21 · 2014: 24 · 2013: 24 · 2012: 45
FWCI: 70.71
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
U.S. Department of Energy
Topics: Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords: neurofibromatosis type 1, NF1 gene, GTPase-activating protein, Ras, open reading frames, cDNA cloning, cell growth regulation, protein homology
MeSH terms: Amino Acid Sequence, Animals, Base Sequence, Cattle, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 17, Cloning, Molecular, Genes, Humans, Information Systems, Molecular Sequence Data, Neurofibromatosis 1, Proteins, Sequence Homology, Nucleic Acid, Translocation, Genetic, Oligonucleotide Probes, Gene Library, Polymerase Chain Reaction, GTPase-Activating Proteins, ras GTPase-Activating Proteins, Neurofibromin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The neurofibromatosis type 1 gene encodes a protein related to GAP

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks